A321550 logo

TiumBio Co., Ltd. Stock Price

KOSDAQ:A321550 Community·₩119.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A321550 Share Price Performance

₩3,990.00
-795.00 (-16.61%)
₩3,990.00
-795.00 (-16.61%)
Price ₩3,990.00

A321550 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with very low risk.

2 Risks
1 Reward

TiumBio Co., Ltd. Key Details

₩13.1b

Revenue

₩8.2b

Cost of Revenue

₩5.0b

Gross Profit

₩19.9b

Other Expenses

-₩14.9b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-495.14
37.91%
-113.25%
62.5%
View Full Analysis

About A321550

Founded
2016
Employees
68
CEO
Huntaek Kim
WebsiteView website
www.tiumbio.com

TiumBio Co., Ltd., a drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases. The company’s products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, and NBP604. It has a collaboration agreement with Oncodesign Société Anonyme for the research and development of fibrosis drug candidates. The company was founded in 2016 and is based in Seongnam-si, South Korea.

Recent A321550 News & Updates

Recent updates

No updates